Pharmacologic Thromboprophylaxis and Thrombosis in Hospitalized Patients with COVID-19: A Pooled Analysis.
Thromb Haemost
; 121(1): 76-85, 2021 Jan.
Article
in English
| MEDLINE | ID: covidwho-1066012
ABSTRACT
BACKGROUND:
Coronavirus disease 2019 (COVID-19) increases thrombosis in hospitalized patients prompting adoption of different thromboprophylaxis strategies. Safety and efficacy of escalated-dose pharmacologic thromboprophylaxis are not established.OBJECTIVES:
To determine the pooled incidence of thrombosis/bleeding in hospitalized patients with COVID-19 for standard-dose, intermediate-dose, therapeutic anticoagulation, and no pharmacologic thromboprophylaxis.METHODS:
MEDLINE, EMBASE, and Cochrane CENTRAL were searched up to August 29, 2020 for studies reporting pharmacologic thromboprophylaxis and thrombosis or bleeding. Pooled event rates were calculated using a random-effects model.RESULTS:
Thirty-five observational studies were included. The pooled incidence rates of total venous thromboembolism (N = 4,685) were no prophylaxis 41.9% (95% confidence interval [CI] 28.1-57.2, I 2 = 76%), standard-dose prophylaxis 19.8% (95% CI 13.2-28.6, I 2 = 95%), intermediate-dose prophylaxis 11.9% (95% CI 4.3-28.6, I 2 = 91%), and therapeutic-dose anticoagulants 10.5% (95% CI 4.2-23.8, I 2 = 82%, p = 0.003). The pooled incidence rates of arterial thrombosis (N = 1,464) were no prophylaxis 11.3% (95% CI 5.2-23.0, I 2 = 0%), standard-dose prophylaxis 2.5% (95% CI 1.4-4.3, I 2 = 45%), intermediate-dose prophylaxis 2.1% (95% CI 0.5-7.7, I 2 = 45%), and therapeutic-dose anticoagulants 1.3% (95% CI 0.2-8.8, I 2 = 0, p = 0.009). The pooled bleeding event rates (N = 6,393) were nonsignificantly higher in therapeutic-dose anticoagulants compared with standard-dose prophylaxis, (6.3 vs. 1.7%, p = 0.083).CONCLUSION:
Thrombosis rates were lower in hospitalized COVID-19 patients who received pharmacologic thromboprophylaxis. Thrombosis and bleeding rates for patients receiving intermediate-dose thromboprophylaxis or therapeutic anticoagulation were similar to those who received standard-dose pharmacologic thromboprophylaxis.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Blood Coagulation
/
Venous Thromboembolism
/
Fibrinolytic Agents
/
SARS-CoV-2
/
COVID-19 Drug Treatment
/
Hospitalization
Type of study:
Observational study
/
Prognostic study
/
Randomized controlled trials
/
Reviews
Limits:
Humans
Language:
English
Journal:
Thromb Haemost
Year:
2021
Document Type:
Article
Affiliation country:
S-0040-1721664
Similar
MEDLINE
...
LILACS
LIS